Odile Lacroix

Title: Odile Lacroix: Innovator in Human Fertility Treatment

Introduction

Odile Lacroix is a notable inventor based in Aix-en-Provence, France. She has made significant contributions to the field of human fertility treatment through her innovative research and inventions. Her work focuses on improving the selection process for in vitro-fertilized embryos, which can enhance the chances of successful implantation.

Latest Patents

Odile Lacroix holds a patent titled "Use of soluble CD146 as a biomarker to select in vitro-fertilized embryo for implantation in a mammal." This invention identifies soluble CD146 (sCD146) as a biomarker that can be measured in an embryo culture medium. The measurement of sCD146 helps determine whether an embryo is suitable for implantation in the uterus of a mammal. This groundbreaking invention provides a new tool and related kits for (pre)selecting embryos eligible for implantation. Additionally, it includes methods for promoting pregnancy in humans undergoing embryo transfer.

Career Highlights

Throughout her career, Odile Lacroix has worked with esteemed institutions such as the Centre Hospitalier Universitaire de Nîmes and the Institut National de la Santé et de la Recherche Médicale. Her experience in these organizations has allowed her to collaborate with leading experts in the field of fertility treatment.

Collaborations

Odile has collaborated with notable colleagues, including Nathalie Bardin and Marcel Blot-Chabaud. These partnerships have contributed to her research and the development of her innovative patent.

Conclusion

Odile Lacroix's contributions to human fertility treatment through her patent on soluble CD146 exemplify her dedication to advancing medical science. Her work not only enhances the selection process for embryos but also promotes successful pregnancies, making a significant impact in the field.